Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Payne

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
The British Journal of Dermatology|February 9, 2016
Delayed oral toxicity from long-term vemurafenib therapyA Lloyd-Lavery, T Hodgson, N Coupe, et al.
British Journal of Cancer|May 19, 2011
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancerO A Khan, A D Blann, M J Payne, et al.
Clinical and Experimental Immunology|August 1, 2020
Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitisS C Sasson, J J Zaunders, K Nahar, et al.
Analytical and Bioanalytical Chemistry|December 1, 2011
Development and certification of green tea-containing standard reference materialsL C Sander, M Bedner, M C Tims, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
The British Journal of Dermatology|February 9, 2016
Delayed oral toxicity from long-term vemurafenib therapyA Lloyd-Lavery, T Hodgson, N Coupe, et al.
British Journal of Cancer|May 19, 2011
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancerO A Khan, A D Blann, M J Payne, et al.
Clinical and Experimental Immunology|August 1, 2020
Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitisS C Sasson, J J Zaunders, K Nahar, et al.
Analytical and Bioanalytical Chemistry|December 1, 2011
Development and certification of green tea-containing standard reference materialsL C Sander, M Bedner, M C Tims, et al.
Pageof 4